Home/Filings/4/0001213900-23-021493
4//SEC Filing

MARTELL RON 4

Accession 0001213900-23-021493

CIK 0001788028other

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 5:59 PM ET

Size

5.7 KB

Accession

0001213900-23-021493

Insider Transaction Report

Form 4
Period: 2023-03-17
MARTELL RON
DirectorPresident, CEO and Director
Transactions
  • Award

    Stock Option (right to buy)

    2023-03-17+500,000500,000 total
    Exercise: $1.87Exp: 2033-03-17Voting Common Stock (500,000 underlying)
Footnotes (1)
  • [F1]1/4th of the shares subject to the option shall vest on March 3, 2024, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Issuer

Jasper Therapeutics, Inc.

CIK 0001788028

Entity typeother

Related Parties

1
  • filerCIK 0001177079

Filing Metadata

Form type
4
Filed
Mar 19, 8:00 PM ET
Accepted
Mar 20, 5:59 PM ET
Size
5.7 KB